NASDAQ:ANNX • US03589W1027
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ANNEXON INC (ANNX).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-12-23 | Chardan Capital | Initiate | Buy |
| 2025-12-02 | Clear Street | Initiate | Buy |
| 2025-11-19 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-08-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-05-14 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-05-13 | Needham | Maintains | Buy -> Buy |
| 2025-03-04 | Needham | Reiterate | Buy -> Buy |
| 2024-12-17 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-15 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-11-15 | Needham | Reiterate | Buy -> Buy |
| 2024-11-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-09 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-08-13 | Needham | Reiterate | Buy -> Buy |
| 2024-08-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-05 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-06-04 | Needham | Reiterate | Buy -> Buy |
| 2024-06-04 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-15 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2024-05-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-13 | Needham | Reiterate | Buy -> Buy |
| 2024-04-24 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-04-11 | Needham | Reiterate | Buy -> Buy |
| 2024-04-03 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-04-01 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2024-04-01 | JP Morgan | Maintains | Overweight -> Overweight |
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A -44.39% | N/A 464.65% | N/A 62.49% | N/A 61.33% | N/A 8.26% | N/A 20.27% | N/A 13.47% | |||||||||
| EBITDA YoY % growth | -20.21M | -18.66M 7.67% | -32.03M -71.65% | -62.8M -96.07% | -128.57M -104.73% | -143.49M -11.60% | -141.575M 1.33% | -151.923M -7.31% | N/A -49.91% | N/A -5.55% | N/A -15.41% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -20.48M | -19.15M 6.49% | -32.52M -69.82% | -63.47M -95.17% | -130.71M -105.94% | -145.6M -11.39% | -143.723M 1.29% | -154.073M -7.20% | N/A -46.35% | N/A 7.62% | N/A 12.24% | N/A 137.39% | N/A 251.97% | N/A 122.33% | N/A -29.12% | N/A 37.42% | N/A 15.45% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | -3.40 11.59% | -2.87 15.59% | -1.78 37.98% | -1.02 42.70% | N/A -39.29% | N/A 25.74% | N/A 22.25% | N/A 142.90% | N/A 209.19% | N/A 108.43% | N/A -13.19% | N/A 29.02% | N/A 14.86% |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.33 1.49% | -0.33 9.69% | -0.33 3.34% | -0.28 24.41% | -0.26 19.30% |
| Revenue Q2Q % growth | 1.494M | ||||
| EBITDA Q2Q % growth | -59.558M -19.47% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -56.894M -9.41% | -55.819M 2.76% | -54.915M -6.17% | -53.056M 6.95% | -50.678M 10.93% |
All data in USD
16 analysts have analysed ANNX and the average price target is 15.01 USD. This implies a price increase of 176.4% is expected in the next year compared to the current price of 5.43.
ANNEXON INC (ANNX) will report earnings on 2026-03-09, after the market close.
The consensus EPS estimate for the next earnings of ANNEXON INC (ANNX) is -0.33 USD and the consensus revenue estimate is 0 USD.